SLU-PP-332 250mcg x 100tabs (EVOLIX)

SLU-PP-332 250μg x 100 tablets (EVOLIX)

SLU-PP-332 250μg x 100 tablets (EVOLIX)

SLU-PP-332 is an exercise mimetic drug that has shown perceptible results in terms of weight loss and improved cardiac function in early trials. SLU-PP-332 improves exercise performance
Metabolic pathways: SLU-PP-332 mimics exercise-induced metabolic pathways
Potential uses
Treatment of type 2 diabetes, obesity, nonalcoholic fatty liver disease, heart failure, and kidney disease
Delaying age-related disease
Muscle regeneration in people with muscular diseases
Safety and Concomitants
SLU-PP-332 has not shown significant side effects in early trials, but further studies are needed
SLU-PP-332’s transient effects may disappear when use is discontinued
In humans, the balance between side effects and efficacy may be difficult
Other studies
SLU-PP-332 activates estrogen receptor-related orphan receptors (ERRs) in various human organs
ERR activity may also be considered in Alzheimer’s disease and other neurodegenerative diseases.
Recommended dosage

Beginner: 250mcg twice a day (500mcg daily)

Intermediate: 500mcg twice a day (10,000mg daily)

Advanced: 1000mg twice a day (2000mg daily)

Video reference